Afrigen Biologics | HealthCare Africa Magazine

New consortium working to boost vaccine production in South Africa

31 July 202131 July 2021 Frank

SOUTH AFRICA – The World Health Organization (WHO), together with a few other concerned organizations have formed a consortium, officiated by a letter of intent to address the global imbalance of manufacturing capacity for COVID-19 vaccines. The consortium, consisting of the Medicines Patent Pool (MPP), Afrigen Biologics (PTY) Limited, the Biologicals and Vaccines Institute of Southern Africa (Biovac), the South African Medical Research Council (SAMRC) and Africa Centres for Disease Control and Prevention (Africa CDC), will establish the South African mRNA technology transfer hub. This hub will allow for greater…

Afrigen gears up to deliver Africa’s first COVID-19 mRNA vaccine

25 June 202125 June 2021 Frank

SOUTH AFRICA – Afrigen Biologics expects a decision in mid-July on partners to produce Africa’s first COVID-19 vaccine using the mRNA platform, the South African start-up’s managing director said. The World Health Organization picked Afrigen for a pilot to give poor and middle-income countries the know-how and licenses to make COVID-19 vaccines, in what South African President Cyril Ramaphosa called an historic step. The “tech transfer hub” will make it possible for African companies to manufacture mRNA vaccines, the advanced technology used in Pfizer and Moderna shots, in 9-12 months,…